Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial

BACKGROUND: A second antipsychotic is commonly added to clozapine to treat refractory schizophrenia, notwithstanding the limited evidence to support such practice. METHODS: The efficacy and adverse effects of this pharmacological strategy were examined in a double-blind, placebo-controlled, 12-week...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnes, Thomas R.E., Leeson, Verity, Paton, Carol, Marston, Louise, Osborn, David P., Kumar, Raj, Keown, Patrick, Zafar, Rameez, Iqbal, Khalid, Singh, Vineet, Fridrich, Pavel, Fitzgerald, Zachary, Bagalkote, Hemant, Haddad, Peter M., Husni, Mariwan, Amos, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022882/
https://www.ncbi.nlm.nih.gov/pubmed/29977519
http://dx.doi.org/10.1177/2045125318762365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022882/
https://www.ncbi.nlm.nih.gov/pubmed/29977519
http://dx.doi.org/10.1177/2045125318762365

Ejemplares similares